TickerFacts.

Semnur Pharmaceuticals, Inc. (SMNR): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$20.75M
As of 2025-12-31
-$29.67M
As of 2026-06-30
2022-12-31: -$3.27M2023-12-31: -$8.28M2024-12-31: -$42.78M2025-12-31: -$20.75M-$20.75M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$20.75Mn/m2026-02-27, Balance as of period end
2024-12-31-$42.78Mn/m2026-02-27, Balance as of period end
2023-12-31-$8.28Mn/m2025-04-02, Balance as of period end
2022-12-31-$3.27Mn/a2024-04-01, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Semnur Pharmaceuticals, Inc. (SMNR)2025-12-31-$20.75Mn/m
Aspire Biopharma Holdings, Inc. (ASBP)2025-12-31-$6.38Mn/m
Accustem Sciences Inc. (ACUT)2025-12-31-$3.40Mn/m
NeuroSense Therapeutics Ltd. (NRSN)2025-12-31-$1.56Mn/m
Ocean Biomedical, Inc. (OCEA)2024-12-31-$97.62Mn/a
Alzamend Neuro, Inc. (ALZN)2026-04-30$733.2K-81.5%
Inhibitor Therapeutics, Inc. (INTI)2025-12-31-$1.29Mn/m
Vaccinex, Inc. (VCNX)2024-12-31-$2.49Mn/m
Provectus Biopharmaceuticals, Inc. (PVCT)2025-12-31-$6.30Mn/m

Compare SMNR, ASBP, ACUT, NRSN side by side · Screen every company in Pharmaceutical Preparations ↗